Xenon Pharmaceuticals to Present Azetukalner and Epilepsy Data at AES 2025 Webinar
Xenon Pharmaceuticals Inc. will host a webinar titled “Azetukalner and Epilepsy Data Update: AES 2025” on December 10, 2025. The event will provide updates on the commercialization of azetukalner. A live webcast will be available on Xenon's website, with a replay option. This announcement was originally published by Xenon Pharmaceuticals via GlobeNewswire.
Xenon Pharmaceuticals Inc. will host a webinar titled “Azetukalner and Epilepsy Data Update: AES 2025” on Wednesday, December 10, 2025, from 10:00 to 11:00 AM Eastern Time. The event will include an update on the company’s progress in preparing for the commercialization of azetukalner, and questions can be submitted in advance or during the live session. A live webcast will be available on the Investors section of Xenon’s website and will be posted for replay following the event. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xenon Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9595650-en) on December 03, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
